For the Inventor, By the Inventor

Enter assignee name

Durham, NC, United States of America

Icagen, Inc.

USPTO Granted Patents = 101

CIPO Patents = 5

EPO Patents = 26

Trademarks = 5

Forward Citations = 547

Loading Chart...

Loading Chart...

90 inventors (with patents filed for the assignee):

Timothy James Jegla (24 out of 24 patents)

Michael F Gross (20 out of 28 patents)

Benjamin P Warner (17 out of 46 patents)

4. Serge Beaudoin (15 out of 16 patents)

5. Grant Andrew McNaughton-Smith (14 out of 14 patents)

6. Brian Edward Marron (13 out of 35 patents)

7. Xiaodong Wang (12 out of 37 patents)

8. Alan Bradley Fulp (12 out of 15 patents)

9. Lori J Peterson (11 out of 14 patents)

10. Alan David Wickenden (11 out of 12 patents)

11. George Salvatore Amato (10 out of 11 patents)

12. Mark J Suto (9 out of 34 patents)

13. Nathan H Zahler (9 out of 10 patents)

14. Jennifer A Berger (9 out of 13 patents)

15. Eva Rachel Birnbaum (9 out of 20 patents)

Core Competencies:

X-Ray Fluorescence

Analyte Transport

Protein Post-Translational Modification

Drug Development

Ion Channel Inhibitors

Potassium Channel Modulators

Sodium Channel Inhibitors

Chemical Compounds

Heterocycles

Calcium Channel Antagonists

Sensor Arrays

Well Plates

101 patents: Sort by Forward Citations

1. 11639941 - Methods for measuring analyte transport across barriers using X-ray fluorescence (2023-05-02),

2. 11598759 - Sensors and sensor arrays for detection of analytes (2023-03-07),

3. 11573224 - Methods of detection using X-ray fluorescence (2023-02-07),

4. 11561188 - Method and apparatus for measuring protein post-translational modification (2023-01-24),

5. 10948437 - Method for analysis using X-ray fluorescence (2021-03-16),

6. 10877035 - Advanced drug development and manufacturing (2020-12-29),

7. 10782253 - Well plate (2020-09-22),

8. 10577642 - Method and apparatus for measuring protein post-translational modification (2020-03-03),

9. 10527600 - Sensors and sensor arrays for detection of analytes (2020-01-07),

10. 10458933 - Method for analysis using X-ray fluorescence (2019-10-29),

11. 10082511 - Methods for measuring analyte transport across barriers using X-ray fluorescence (2018-09-25),

12. 10082474 - Method for analysis using X-ray fluorescence (2018-09-25),

13. 9976172 - Method and apparatus for measuring protein post-translational modification (2018-05-22),

14. 9506931 - Method for measuring analyte transport across cell membranes using X-ray fluorescence (2016-11-29),

15. 9476846 - Well plate (2016-10-25),

Icagen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing novel small molecule drugs that address unmet medical needs in the areas of neuroscience, pain, and rare diseases. With a passion for innovation, Icagen leverages its expertise in medicinal chemistry, molecular pharmacology, and electrophysiology to drive drug discovery programs. By collaborating with partners and utilizing cutting-edge technologies, Icagen aims to improve patients' lives through the development of breakthrough therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

101 Patents

#10 in Durham, NC

#91 in North Carolina

#3,617 in US

#7,499 in the World

Durham, NC, United States of America

Icagen, Inc.

Forward Citations = 547

90 inventors:

Timothy James Jegla (24 out of 24 patents)

Michael F Gross (20 out of 28 patents)

Benjamin P Warner (17 out of 46 patents)

4. Serge Beaudoin (15 out of 16 patents)

5. Grant Andrew McNaughton-Smith (14 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…